Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Infections

Explore clinical trials studying Respiratory Tract Infections. Study availability and eligibility vary by location and protocol.

9,597 public trials 647 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Infections trial results

Completed

Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine

NCT04969276

Conditions
Healthy Volunteers, Infections, Influenza Immunization, +6 more
Locations
  • Investigational Site Number :8400003 Glendale, Arizona, United States
  • Investigational Site Number :8400006 San Diego, California, United States
  • Investigational Site Number :8400004 Vista, California, United States
  • Investigational Site Number :8400005 Centennial, Colorado, United States
View Trial Details
Completed

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

NCT06156215

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • San Francisco General Hospital Emergency Department San Francisco, California, United States
  • University of California San Francisco Parnassus San Francisco, California, United States
  • Duke University Hospital Durham, North Carolina, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above

NCT05829356

Conditions
Infections, Influenza Immunization, Influenza, Human, +5 more
Locations
  • Investigational Site Number : 0360004 Herston, Queensland, Australia
  • Investigational Site Number : 0360001 Morayfield, Queensland, Australia
  • Investigational Site Number : 0360002 Camberwell, Victoria, Australia
  • Investigational Site Number : 0360003 Adelaide, Australia
View Trial Details
Completed

Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South Korea

NCT05144945

Conditions
Infections, Influenza (Healthy Volunteers), Influenza, Human, +5 more
Locations
  • Investigational Site Number :4100003 Ansan-si, Gyeonggi-do, South Korea
  • Investigational Site Number :4100001 Seoul, Seoul-teukbyeolsi, South Korea
  • Investigational Site Number :4100002 Seoul, South Korea
View Trial Details
Completed

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

NCT06680375

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • GSK Investigational Site Anniston, Alabama, United States
  • GSK Investigational Site Rolling Hills Estates, California, United States
  • GSK Investigational Site Hialeah, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
View Trial Details

Related conditions